牛牛AI助理已提取核心訊息
On December 31, 2023, Hudson Bay Capital Management LP, an investment management firm based in Delaware, and Sander Gerber, its managing member, filed an amended Schedule 13G/A with the SEC, indicating a change in their holdings of Conduit Pharmaceuticals Inc. The filing revealed that Hudson Bay Capital Management LP and Sander Gerber collectively own 73,078 shares of Conduit Pharmaceuticals' common stock, which are issuable upon the exercise of warrants. This represents 0.10% of the company's class of securities, based on 73,829,536 shares outstanding as of December 15, 2023. The shares are held by HB Strategies LLC, with the Investment Manager serving as the investment manager to HB Strategies LLC. Sander Gerber, as the managing member of Hudson Bay Capital GP LLC, which is the general partner of the Investment Manager, disclaims beneficial ownership of these securities. The filing also certifies that the securities were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of Conduit Pharmaceuticals.
On December 31, 2023, Hudson Bay Capital Management LP, an investment management firm based in Delaware, and Sander Gerber, its managing member, filed an amended Schedule 13G/A with the SEC, indicating a change in their holdings of Conduit Pharmaceuticals Inc. The filing revealed that Hudson Bay Capital Management LP and Sander Gerber collectively own 73,078 shares of Conduit Pharmaceuticals' common stock, which are issuable upon the exercise of warrants. This represents 0.10% of the company's class of securities, based on 73,829,536 shares outstanding as of December 15, 2023. The shares are held by HB Strategies LLC, with the Investment Manager serving as the investment manager to HB Strategies LLC. Sander Gerber, as the managing member of Hudson Bay Capital GP LLC, which is the general partner of the Investment Manager, disclaims beneficial ownership of these securities. The filing also certifies that the securities were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of Conduit Pharmaceuticals.
2023年12月31日，總部位於特拉華州的投資管理公司哈德遜灣資本管理有限責任公司及其管理成員桑德·格柏向美國證券交易委員會提交了經修訂的附表13G/A，表明其對Conduit Pharmicals Inc的持股發生了變化。該文件顯示，哈德遜灣資本管理有限責任公司和桑德·格柏共擁有康德伊特製藥公司的73,078股普通股，可在行使認股權證時發行。根據截至2023年12月15日已發行的73,829,536股股票，這佔公司證券類別的0.10％。這些股票由HB Strategies LLC持有，投資經理擔任HB Strategies LLC的投資經理。作爲投資管理公司的普通合夥人哈德遜灣資本集團有限責任公司的管理成員，桑德·格伯宣佈放棄對這些證券的實益所有權。該文件還證明，這些證券是在正常業務過程中收購的，不是爲了改變或影響Conduit Pharmicals的控制權。
2023年12月31日，總部位於特拉華州的投資管理公司哈德遜灣資本管理有限責任公司及其管理成員桑德·格柏向美國證券交易委員會提交了經修訂的附表13G/A，表明其對Conduit Pharmicals Inc的持股發生了變化。該文件顯示，哈德遜灣資本管理有限責任公司和桑德·格柏共擁有康德伊特製藥公司的73,078股普通股，可在行使認股權證時發行。根據截至2023年12月15日已發行的73,829,536股股票，這佔公司證券類別的0.10％。這些股票由HB Strategies LLC持有，投資經理擔任HB Strategies LLC的投資經理。作爲投資管理公司的普通合夥人哈德遜灣資本集團有限責任公司的管理成員，桑德·格伯宣佈放棄對這些證券的實益所有權。該文件還證明，這些證券是在正常業務過程中收購的，不是爲了改變或影響Conduit Pharmicals的控制權。
有用
沒用
